Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Gross Profit (2024 - 2025)

Carlsmed (CARL) has disclosed Gross Profit for 2 consecutive years, with $9.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit rose 106.9% year-over-year to $9.9 million, compared with a TTM value of $30.6 million through Sep 2025, changed N/A, and an annual FY2025 reading of $38.0 million, up 89.74% over the prior year.
  • Gross Profit was $9.9 million for Q3 2025 at Carlsmed, up from $8.9 million in the prior quarter.
  • Across five years, Gross Profit topped out at $9.9 million in Q3 2025 and bottomed at $4.8 million in Q3 2024.